Mar 15, 2017, 12:16 PM by Michael Croft

- Mar 15, 2017 - The Pistoia Alliance Tackles Laboratory Safety with the Launch of the Chemical Safety Library ServiceCollaborative database of previously inaccessible hazardous chemical reactions improves safety for scientists carrying out experiments in the labBoston, 15 March, 2017 - The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, has today announced the launch of the Chemical Safety Library (CSL) Service, which allows hazardous reaction information to be captured, stored and shared, to improve laboratory safety

Mar 15, 2017, 08:30 AM by Michael Croft

Bio-IT World Brief | Oxford Nanopore announced the launch of the GridION X5 today, a new system that can drive up to five MinION Flow Cells and process all the data produced within a single benchtop device.

Mar 14, 2017, 17:26 PM by Michael Croft

PASADENA, CA - Mar 14, 2017 - Deep 6 AI, an artificial intelligence-enabled technology platform for matching patients to clinical trials, took home first prize in the Enterprise and Smart Data category at the 9th annual SXSW Accelerator competition, the marquee event of the South by Southwest® (SXSW®) Conference and Festivals (March 10-19, 2017)  Startup Village®

Mar 14, 2017, 14:37 PM by Michael Croft

BAR HARBOR, ME - Mar 14, 2017 -               Center Inaugurated with New Course on 'Bridging Disciplines' BAR HARBOR, MAINE -- The MDI Biological Laboratory inaugurates its Center for Science Entrepreneurship this week with a new course that will help University of Maine and College of the Atlantic science and engineering undergraduates explore approaches to biomedical research using concepts and tools that promote collaboration across disciplines

Mar 14, 2017, 12:47 PM by Michael Croft

PALO ALTO, CA - Mar 14, 2017 - twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, today announced that its candidate targeting hepatocellular carcinoma (HCC or Liver Cancer), TXR-311, has shown positive results in cell-based assays

Mar 14, 2017, 12:36 PM by Michael Croft

BOSTON, US, & GUILDFORD, UNITED KINGDOM - Mar 14, 2017 - After The E-WorkBook Cloud launch earlier this year, IDBS has now enhanced its capabilities by adding a pre-qualified service to the suite, which has been designed to help organizations streamline their compliance processes for good practice (GxP) regulated systems

Mar 14, 2017, 10:10 AM by Michael Croft

Bio-IT World Brief | An international team of researchers has conducted the first study of its kind to look at the genomic underpinnings of obesity in continental Africans and African Americans.

Mar 13, 2017, 17:25 PM by Michael Croft

Bio-IT World Brief | More than 90 genomics researchers gathered recently for the launch of the Qatar Genome Programme’s research consortium (QGPRC). The consortium is the latest step in QGP’s precision medicine implementation efforts.

Mar 13, 2017, 10:51 AM by Michael Croft

FORT MYERS, FL, UNITED STATES - Mar 13, 2017 - NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, and Definiens, the leader in Tissue Phenomics® solutions from biomarker discovery to meaningful diagnostics, today announced that they have expanded their alliance to develop and automate the analysis of new biomarker assays for clinical trials and routine clinical testing

Mar 13, 2017, 10:42 AM by Michael Croft

Xconomy | This seems to be a watershed year for CAR-T therapy. The field's first-ever regulatory approval is looking like a strong possibility. However, the supercharged T cells remain an enigma.

Mar 13, 2017, 10:31 AM by Michael Croft

VANCOUVER, BC, CANADA - Mar 13, 2017 - Precision NanoSystems has launched the NanoAssemblr™ Scale-Up system to support the clinical development of nanomedicines

Mar 13, 2017, 10:03 AM by Michael Croft

KARLSRUHE, GERMANY - Mar 13, 2017 - Physik Instrumente (PI), a long-established provider of specialist motion control and nanopositioning systems, has announced the recent acquisition of ACS Motion Control, an Israeli developer and manufacturer of high-end controllers and drives for multi-axis systems

Mar 10, 2017, 14:15 PM by Michael Croft

BAR HARBOR, ME - Mar 10, 2017 - Scientists at the MDI Biological Laboratory and Novo Biosciences have identified a drug candidate to restore heart muscle function following a heart attack

Mar 10, 2017, 13:25 PM by Michael Croft

THORNWOOD, NY, UNITED STATES - Mar 10, 2017 - ZEISS introduces two new digital microscope cameras; ZEISS Axiocam 702 mono and ZEISS Axiocam 512 color complement the current portfolio of high-speed USB 3

Mar 9, 2017, 20:10 PM by Michael Croft

PASADENA, CA - Mar 9, 2017 - We’re excited to announce that we are changing our name from Deep 6 Analytics to Deep 6 AI effective March 9, 2017

Mar 9, 2017, 12:27 PM by Michael Croft

CARLSBAD, CA, UNITED STATES - Mar 9, 2017 -  For Immediate Release—Giessen, Germany and Carlsbad, CA, USA, March 9, 2017. Justus-Liebig-University Giessen has added TimeLogic’s latest Field Programmable Gate Array (FPGA) hardware to their computational tools platform

Mar 9, 2017, 11:38 AM by Michael Croft

EDOMA, ME, UNITED STATES - Mar 9, 2017 - Equus Compute Solutions, one of the largest manufacturers of custom white box servers and storage solutions, announces the appointment of Costa Hasapopoulos as President

Mar 9, 2017, 09:40 AM by Michael Croft

Bio-IT World | As the sheer complexity of the microbiome threatens to slow scientific progress, researchers tackle data dilemmas by harnessing the power of free and open source analysis tools.

Mar 9, 2017, 08:11 AM by Michael Croft

PRINCETON, NJ - Mar 9, 2017 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced the launch of Simcyp® Access

Mar 7, 2017, 12:45 PM by Michael Croft

Bio-IT World Brief | A two-year grant totaling $455,000 from the National Institutes of Health to The Jackson Laboratory will support research to improve the accuracy and efficiency of genome editing for research, drug testing, and future therapeutic delivery.